People who use aspirin at least once a month may have a reduced risk of developing pancreatic cancer US scientists have discovered. A research team at the Mayo Clinic in Rochester, Minnesota studied 904 patients with pancreatic cancer and a further 1,224 healthy patients, all over 55.
Participants provided information on their use of aspirin, non-steroidal anti-inflammatory drugs (NSAIDs) and paracetamol.Preliminary findings suggest that people who took aspirin at least one day per month were 26% less likely to develop pancreatic cancer than those who did not take it regularly. No such benefit was found for those who took non-aspirin NSAIDS or paracetamol.
